Bath Savings Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.72M Sell
16,556
-46
-0.3% -$25.8K 0.9% 29
2026
Q1
$9.33M Sell
16,602
-769
-4% -$493K 1% 26
2025
Q4
$11.8M Sell
17,371
-298
-2% -$203K 1.17% 22
2025
Q3
$11.3M Sell
17,669
-75
-0.4% -$45.5K 1.12% 29
2025
Q2
$9.52M Sell
17,744
-340
-2% -$163K 0.96% 32
2025
Q1
$7.59M Sell
18,084
-422
-2% -$183K 0.79% 35
2024
Q4
$7.65M Sell
18,506
-3,308
-15% -$1.45M 0.78% 34
2024
Q3
$11M Sell
21,814
-157
-0.7% -$76.3K 1.1% 30
2024
Q2
$10.7M Sell
21,971
-634
-3% -$318K 1.14% 28
2024
Q1
$12.2M Sell
22,605
-1,121
-5% -$613K 1.3% 28
2023
Q4
$13.2M Buy
23,726
+221
+0.9% +$104K 1.48% 23
2023
Q3
$10.3M Sell
23,505
-343
-1% -$171K 1.26% 28
2023
Q2
$12M Sell
23,848
-93
-0.4% -$44.6K 1.4% 24
2023
Q1
$12M Sell
23,941
-500
-2% -$239K 1.47% 24
2022
Q4
$9.97M Sell
24,441
-290
-1% -$113K 1.29% 25
2022
Q3
$8.06M Buy
24,731
+1,473
+6% +$541K 1.12% 29
2022
Q2
$8.16M Sell
23,258
-26
-0.1% -$10.6K 1.07% 30
2022
Q1
$12.7M Sell
23,284
-483
-2% -$254K 1.45% 25
2021
Q4
$15.7M Sell
23,767
-789
-3% -$495K 1.63% 22
2021
Q3
$15.3M Sell
24,556
-675
-3% -$454K 1.77% 21
2021
Q2
$15.9M Sell
25,231
-615
-2% -$340K 1.88% 21
2021
Q1
$12.6M Sell
25,846
-1,390
-5% -$696K 1.61% 23
2020
Q4
$13.6M Sell
27,236
-450
-2% -$201K 1.8% 22
2020
Q3
$10.9M Sell
27,686
-460
-2% -$170K 1.79% 22
2020
Q2
$9.29M Sell
28,146
-204
-0.7% -$59.1K 1.68% 23
2020
Q1
$6.87M Buy
28,350
+743
+3% +$194K 1.49% 26
2019
Q4
$7.21M Sell
27,607
-106
-0.4% -$27.9K 1.3% 29
2019
Q3
$7.54M Sell
27,713
-640
-2% -$178K 1.45% 27
2019
Q2
$7.81M Sell
28,353
-114
-0.4% -$28.1K 1.55% 23
2019
Q1
$6.37M Sell
28,467
-271
-0.9% -$55.9K 1.34% 25
2018
Q4
$5.35M Sell
28,738
-318
-1% -$65.2K 1.33% 26
2018
Q3
$7.25M Sell
29,056
-233
-0.8% -$56.6K 1.58% 23
2018
Q2
$6.38M Sell
29,289
-605
-2% -$125K 1.5% 25
2018
Q1
$5.72M Sell
29,894
-410
-1% -$75.7K 1.43% 26
2017
Q4
$4.74M Sell
30,304
-845
-3% -$133K 1.19% 30
2017
Q3
$4.84M Sell
31,149
-1,485
-5% -$235K 1.29% 28
2017
Q2
$5.27M Sell
32,634
-3,105
-9% -$504K 1.46% 27
2017
Q1
$5.53M Sell
35,739
-4,770
-12% -$658K 1.61% 22
2016
Q4
$4.75M Sell
40,509
-2,658
-6% -$303K 1.46% 24
2016
Q3
$4.87M Sell
43,167
-918
-2% -$96.8K 1.52% 23
2016
Q2
$4.09M Sell
44,085
-380
-0.9% -$32.6K 1.28% 27
2016
Q1
$3.48M Sell
44,465
-206
-0.5% -$14.8K 1.12% 30
2015
Q4
$3.26M Buy
44,671
+1,138
+3% +$81.2K 1.09% 31
2015
Q3
$3.23M Buy
43,533
+4,087
+10% +$293K 1.14% 33
2015
Q2
$2.53M Buy
39,446
+12,692
+47% +$879K 0.86% 37
2015
Q1
$2.07M Sell
26,754
-1,200
-4% -$93.4K 0.7% 41
2014
Q4
$2.07M Buy
27,954
+1,800
+7% +$126K 0.71% 45
2014
Q3
$1.54M Buy
26,154
+550
+2% +$34.8K 0.58% 47
2014
Q2
$1.71M Sell
25,604
-90
-0.4% -$5.72K 0.65% 46
2014
Q1
$1.56M Buy
25,694
+200
+0.8% +$11.9K 0.62% 48
2013
Q4
$1.36M Sell
25,494
-850
-3% -$44.7K 0.54% 49
2013
Q3
$1.31M Buy
26,344
+180
+0.7% +$8.65K 0.57% 48
2013
Q2
$1.17M Buy
+26,164
New +$1.14M 0.55% 52

Other funds holding IDXX

Bath Savings Trust's IDXX Position: Q2 2026 in Review

Bath Savings Trust reduced its Idexx Laboratories (IDXX) stake by 0.28% in Q2 2026, selling an estimated $25.8K and leaving 16,556 shares worth $8.72M. The position accounts for 0.9% of the portfolio, ranked #29.

Bath Savings Trust first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.9M in Q2 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bath Savings Trust held 16,556 shares of Idexx Laboratories worth $8.72M as of Q2 2026.
  • Bath Savings Trust sold 46 Idexx Laboratories shares in Q2 2026, an estimated $25.8K.
  • Idexx Laboratories made up 0.9% of Bath Savings Trust's portfolio in Q2 2026, its #29 holding.
  • Bath Savings Trust first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Bath Savings Trust's Idexx Laboratories position peaked at $15.9M in Q2 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bath Savings Trust's 13F filing for Q2 2026, filed 9 Jul 2026.